Abstract
Antiviral drug therapy can effectively suppress HIV replication, but emerging viral resistance and drug toxicity limit long-term therapeutic efficacy. In addition, regeneration of the T helper cell repertoire is often incomplete. The current major challenges in the treatment of HIV infection are therefore the reconstitution of cellular immunity, and especially of the HIV-specific immune response, and the suppression of virus replication in patients with HAART failure. Several gene therapeutic strategies for immune reconstitution of AIDS patients have been described. Preclinical and clinical studies have examined the safety and efficacy of two basic approaches: firstly, the transfer of autologous T cells armed with recombinant receptors that target HIV antigens to specifically increase antiviral immunity and, secondly, the transfer of genetically modified T cells or hematopoietic progenitor cells that express an antiviral gene. However, for both approaches, engraftment levels of gene-modified cells have not been sufficient to reconstitute cellular immunity and to effectively reduce the overall viral load in patients. Strategies to improve the technologies and procedures involved in gene therapeutic immune reconstitution of AIDS patients are discussed.
Keywords: HIV infection, stem cell transplantation, T cell therapy, immune reconstitution
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Title: Gene Therapeutic Approaches for Immune Modulation in AIDS
Volume: 6 Issue: 2
Author(s): Dorothee von Laer, Christopher Baum, Axel Schambach, Klaus Kuhlcke, Roland Zahn, Sebastian Newrzela, Jan van Lunzen, R. Paul Johnson and Jorn E. Schmitz
Affiliation:
Keywords: HIV infection, stem cell transplantation, T cell therapy, immune reconstitution
Abstract: Antiviral drug therapy can effectively suppress HIV replication, but emerging viral resistance and drug toxicity limit long-term therapeutic efficacy. In addition, regeneration of the T helper cell repertoire is often incomplete. The current major challenges in the treatment of HIV infection are therefore the reconstitution of cellular immunity, and especially of the HIV-specific immune response, and the suppression of virus replication in patients with HAART failure. Several gene therapeutic strategies for immune reconstitution of AIDS patients have been described. Preclinical and clinical studies have examined the safety and efficacy of two basic approaches: firstly, the transfer of autologous T cells armed with recombinant receptors that target HIV antigens to specifically increase antiviral immunity and, secondly, the transfer of genetically modified T cells or hematopoietic progenitor cells that express an antiviral gene. However, for both approaches, engraftment levels of gene-modified cells have not been sufficient to reconstitute cellular immunity and to effectively reduce the overall viral load in patients. Strategies to improve the technologies and procedures involved in gene therapeutic immune reconstitution of AIDS patients are discussed.
Export Options
About this article
Cite this article as:
von Laer Dorothee, Baum Christopher, Schambach Axel, Kuhlcke Klaus, Zahn Roland, Newrzela Sebastian, van Lunzen Jan, Paul Johnson R. and Schmitz E. Jorn, Gene Therapeutic Approaches for Immune Modulation in AIDS, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2007; 6 (2) . https://dx.doi.org/10.2174/187152307780598081
DOI https://dx.doi.org/10.2174/187152307780598081 |
Print ISSN 1871-5230 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-614X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Novel Immunotherapies for Hematological Malignancies
Current Molecular Pharmacology Detecting Growing Mammary Tumors with Monoclonal Antibodies Against Vascular Endothelial Growth Factor Receptor – 3
Current Radiopharmaceuticals Third Generation Radiopharmaceuticals for Imaging and Targeted Therapy
Current Pharmaceutical Analysis Exploring Confluence-Related Signalling to Modulate the Expression of Oct4 – A Role in Facilitating Mouse Somatic Cell Reprogramming?
Current Stem Cell Research & Therapy Cytotoxic Nucleoside Analogues: Different Strategies to Improve their Clinical Efficacy
Current Medicinal Chemistry Inhibitory Effect of Fruit Juices on the Doxorubicin Metabolizing Activity of Carbonyl Reductase 1
Drug Metabolism Letters Dissecting Bortezomib: Development, Application, Adverse Effects and Future Direction
Current Pharmaceutical Design Pyrazolines: A Biological Review
Mini-Reviews in Medicinal Chemistry Synthesis and Anticancer Activity of Some 1H-inden-1-one Substituted (Heteroaryl)Acetamide Derivatives
Letters in Drug Design & Discovery Transcription Factors as Potential Targets for Therapeutic Drugs
Current Pharmaceutical Biotechnology Insights into a Critical Role of the FOXO3a-FOXM1 Axis in DNA Damage Response and Genotoxic Drug Resistance
Current Drug Targets The Chemistry and Biology of the Bryostatins: Potential PKC Inhibitors in Clinical Development
Current Medicinal Chemistry Phosphodiesterase Type 5 Inhibitors: Unmet Needs
Current Pharmaceutical Design Genetic Polymorphism and Tumor Immunotherapy
Current Pharmacogenomics Natural Products Chemistry in Marine Ascidians of the Genus Aplidium
Mini-Reviews in Organic Chemistry Progress Toward Vector Design for Hematopoietic Stem Cell Gene Therapy
Current Gene Therapy Tyrosine Kinase Inhibitors – A Review on Pharmacology, Metabolism and Side Effects
Current Drug Metabolism Recent Advances in Epitope Design for Immunotherapy of Cancer
Recent Patents on Anti-Cancer Drug Discovery Chemical Libraries Towards Protein Kinase Inhibitors
Combinatorial Chemistry & High Throughput Screening Insight γ-Secretase: Structure, Function, and Role in Alzheimer’s Disease
Current Drug Targets